title: Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
abstract: With recent advances in understanding of the neuroscience of risk taking, attention is now turning to genetic factors that may contribute to individual heterogeneity in risk attitudes. In this paper we test for genetic associations with risk attitude measures derived from both the psychology and economics literature. To develop a long-term prospective study, we first evaluate both types of risk attitudes and find that the economic and psychological measures are poorly correlated, suggesting that different genetic factors may underlie human response to risk faced in different behavioral domains. We then examine polymorphisms in a spectrum of candidate genes that affect neurotransmitter systems influencing dopamine regulation or are thought to be associated with risk attitudes or impulsive disorders. Analysis of the genotyping data identified two single nucleotide polymorphisms (SNPs) in the gene encoding the alpha 4 nicotine receptor (CHRNA4, rs4603829 and rs4522666) that are significantly associated with harm avoidance, a risk attitude measurement drawn from the psychology literature. Novelty seeking, another risk attitude measure from the psychology literature, is associated with several COMT (catechol-O-methyl transferase) SNPs while economic risk attitude measures are associated with several VMAT2 (vesicular monoamine transporter) SNPs, but the significance of these associations did not withstand statistical adjustment for multiple testing and requires larger cohorts. These exploratory results provide a starting point for understanding the genetic basis of risk attitudes by considering the range of methods available for measuring risk attitudes and by searching beyond the traditional direct focus on dopamine and serotonin receptor and transporter genes.
authors.affiliation: Department of Agricultural, Environmental and Development Economics, Ohio State University, Columbus, Ohio, USA. roe.30@osu.edu
authors.forename: Brian E
authors.initials: BE
authors.lastname: Roe
authors.forename: Michael R
authors.initials: MR
authors.lastname: Tilley
authors.forename: Howard H
authors.initials: HH
authors.lastname: Gu
authors.forename: David Q
authors.initials: DQ
authors.lastname: Beversdorf
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Sadee
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Haab
authors.forename: Audrey C
authors.initials: AC
authors.lastname: Papp
mesh_terms: D000328:Adult; D005260:Female; D005376:Financial Management; D006801:Humans; D008297:Male; D010551:Personality; D020641:Polymorphism, Single Nucleotide; D011978:Receptors, Nicotinic / Q000235:genetics*; D012309:Risk-Taking
chemical_list: D011978:Receptors, Nicotinic
references.citation: Drug Alcohol Depend. 2006 Oct 1;84(3):231-9
references.pmid: 16574343
references.citation: Biol Psychiatry. 1997 Dec 1;42(11):1070-2
references.pmid: 9386860
references.citation: Int J Neuropsychopharmacol. 2007 Jun;10(3):309-20
references.pmid: 17176492
references.citation: Arch Gen Psychiatry. 1987 Jun;44(6):573-88
references.pmid: 3579504
references.citation: CNS Spectr. 2008 Apr;13(4):306-15
references.pmid: 18408650
references.citation: Neuropsychologia. 2008 Jan 31;46(2):757-63
references.pmid: 18037454
references.citation: J Neurosci Res. 2009 Feb;87(2):576-85
references.pmid: 18803299
references.citation: J Psychiatry Neurosci. 2007 Nov;32(6):412-6
references.pmid: 18043764
references.citation: J Gambl Stud. 2007 Jun;23(2):113-20
references.pmid: 17205401
references.citation: Addiction. 1998 Sep;93(9):1375-84
references.pmid: 9926543
references.citation: Neuroreport. 2004 Sep 15;15(13):2123-7
references.pmid: 15486494
references.citation: J Hum Genet. 2004;49(1):35-39
references.pmid: 14685824
references.citation: Hum Mol Genet. 2005 May 15;14(10):1393-404
references.pmid: 15829504
references.citation: Curr Opin Neurol. 2007 Aug;20(4):484-92
references.pmid: 17620886
references.citation: Neuropsychologia. 2001;39(4):376-89
references.pmid: 11164876
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):617-22
references.pmid: 19104049
references.citation: PLoS One. 2009;4(2):e4362
references.pmid: 19209222
references.citation: Psychiatr Dev. 1986 Autumn;4(3):167-226
references.pmid: 3809156
references.citation: J Addict Dis. 2001;20(4):91-6
references.pmid: 11760929
references.citation: Am J Psychiatry. 2003 Jan;160(1):47-55
references.pmid: 12505801
references.citation: Genes Brain Behav. 2008 Mar;7(2):164-72
references.pmid: 17559419
references.citation: Arch Neurol. 2007 Feb;64(2):212-6
references.pmid: 17296836
references.citation: J Neural Transm (Vienna). 2003 Dec;110(12):1445-53
references.pmid: 14666415
references.citation: Neuroreport. 2009 Jan 7;20(1):19-23
references.pmid: 19034055
references.citation: Hum Mol Genet. 2006 Jan 15;15(2):299-305
references.pmid: 16339215
references.citation: Nat Genet. 1996 Jan;12(1):78-80
references.pmid: 8528256
references.citation: Neuropsychopharmacology. 2005 Dec;30(12):2263-8
references.pmid: 15988470
references.citation: Am J Med Genet. 2000 Jun 12;96(3):360-4
references.pmid: 10898915
references.citation: Arch Gen Psychiatry. 2007 Sep;64(9):1078-86
references.pmid: 17768273
references.citation: Compr Psychiatry. 2006 Sep-Oct;47(5):350-6
references.pmid: 16905396
references.citation: Hum Genet. 2006 Nov;120(4):447-59
references.pmid: 16896926
references.citation: Psychiatr Genet. 2008 Aug;18(4):167-76
references.pmid: 18628678
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1442-9
references.pmid: 18165969
references.citation: Mol Psychiatry. 2001 Jan;6(1):35-8
references.pmid: 11244482
references.citation: Clin Genet. 2000 Nov;58(5):375-85
references.pmid: 11140838
references.citation: J Affect Disord. 1996 Apr 12;37(2-3):75-9
references.pmid: 8731069
references.citation: Brain Cogn. 2008 Apr;66(3):243-52
references.pmid: 17942206
references.citation: Neuropsychobiology. 2004;50(2):153-6
references.pmid: 15292670
references.citation: Acta Psychiatr Scand. 2000 May;101(5):403-5
references.pmid: 10823301
references.citation: Nat Rev Neurosci. 2004 Jan;5(1):55-65
references.pmid: 14708004
references.citation: Compr Psychiatry. 2007 Sep-Oct;48(5):452-7
references.pmid: 17707254
references.citation: Mol Psychiatry. 2003 Jan;8(1):118-22
references.pmid: 12556917
references.citation: Neuropsychologia. 2007 Sep 20;45(12):2874-81
references.pmid: 17603086
references.citation: Twin Res Hum Genet. 2009 Feb;12(1):103-7
references.pmid: 19210185
references.citation: J Psychiatr Res. 1996 Jan-Feb;30(1):21-7
references.pmid: 8736463
references.citation: Neuroreport. 2005 Jul 13;16(10):1135-8
references.pmid: 15973162
references.citation: Alcohol Clin Exp Res. 2008 Jan;32(1):27-35
references.pmid: 18070248
references.citation: Neuropsychopharmacology. 2007 Sep;32(9):1950-5
references.pmid: 17299513
references.citation: Cereb Cortex. 2008 Jan;18(1):46-52
references.pmid: 17412719
references.citation: Neuroimage. 2003 Aug;19(4):1439-48
references.pmid: 12948701
references.citation: Neuropsychopharmacology. 2005 Jul;30(7):1353-61
references.pmid: 15770238